A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of heteroaryl derivatives of imidazolone compounds of Formula 1. ##STR1## As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
已合成一系列非肽类的NPY拮抗剂,由
咪唑酮化合物的杂环衍
生物组成,其
化学式如下。作为NPY诱导的进食行为的拮抗剂,这些化合物和已知的类似物预计将作为有效的厌食剂,促进体重减轻并治疗进食障碍。